Zobrazeno 1 - 10
of 953
pro vyhledávání: '"Possemato A"'
Autor:
Emily M. Johnson, Kyle Possemato, Matthew Chinman, Gala True, Jacob Hedges, Brittany N. Hampton, E. Jennifer Edelman, Stephen A. Maisto
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-17 (2023)
Abstract Background Individuals seen in Primary Care with behavioral health concerns who decline behavioral health treatment may benefit from the support of peers (consumers in recovery from behavioral health concerns employed to support other consum
Externí odkaz:
https://doaj.org/article/aeeb383690ee4441a7c6eb2a7f919c29
Autor:
Possemato, Kyle, Mastroleo, Nadine R., Balderrama-Durbin, Christina, King, Paul, Davis, Ariella, Borsari, Brian, Rauch, Sheila A.M.
Publikováno v:
In Behavior Therapy May 2024 55(3):570-584
Autor:
Lauren Foltz, Nagashree Avabhrath, Jean-Marc Lanchy, Tyler Levy, Anthony Possemato, Majd Ariss, Bradley Peterson, Mark Grimes
Publikováno v:
iScience, Vol 27, Iss 4, Pp 109585- (2024)
Summary: Knowledge of cell signaling pathways that drive human neural crest differentiation into craniofacial chondrocytes is incomplete, yet essential for using stem cells to regenerate craniomaxillofacial structures. To accelerate translational pro
Externí odkaz:
https://doaj.org/article/23015d337b934de4b9abaaaf6113fc78
Autor:
Michele Maria Luchetti Gentiloni, Valentino Paci, Antonio Carletto, Alen Zabotti, Roberta Ramonda, Maria Sole Chimenti, Lorenzo Dagna, Nicoletta Luciano, Anna Piccinelli, Ivan Giovannini, Giovanni Striani, Nicola Boffini, Gilda Sandri, Niccolò Possemato, Ilenia Pantano, Devis Benfaremo, Carlo Salvarani, Francesco Ciccia, Carlo Selmi, Gianluca Moroncini
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-11 (2023)
Abstract Background Upadacitinib (UPA) is a selective JAK inhibitor recently approved for the treatment of psoriatic arthritis (PsA). In this post-approval study, we aimed to evaluate the effectiveness and safety of UPA over 24 weeks and identify cli
Externí odkaz:
https://doaj.org/article/108d482682b9424eb9e04468ca9fdd9d
Autor:
Foltz, Lauren, Avabhrath, Nagashree, Lanchy, Jean-Marc, Levy, Tyler, Possemato, Anthony, Ariss, Majd, Peterson, Bradley, Grimes, Mark
Publikováno v:
In iScience 19 April 2024 27(4)
Autor:
Amiri, Mehdi, Kiniry, Stephen J., Possemato, Anthony P., Mahmood, Niaz, Basiri, Tayebeh, Dufour, Catherine R., Tabatabaei, Negar, Deng, Qiyun, Bellucci, Michael A., Harwalkar, Keerthana, Stokes, Matthew P., Giguère, Vincent, Kaufman, Randal J., Yamanaka, Yojiro, Baranov, Pavel V., Tahmasebi, Soroush, Sonenberg, Nahum
Publikováno v:
In Cell Reports 23 January 2024 43(1)
Autor:
Mehdi Amiri, Stephen J. Kiniry, Anthony P. Possemato, Niaz Mahmood, Tayebeh Basiri, Catherine R. Dufour, Negar Tabatabaei, Qiyun Deng, Michael A. Bellucci, Keerthana Harwalkar, Matthew P. Stokes, Vincent Giguère, Randal J. Kaufman, Yojiro Yamanaka, Pavel V. Baranov, Soroush Tahmasebi, Nahum Sonenberg
Publikováno v:
Cell Reports, Vol 43, Iss 1, Pp 113615- (2024)
Summary: The integrated stress response (ISR) is critical for cell survival under stress. In response to diverse environmental cues, eIF2α becomes phosphorylated, engendering a dramatic change in mRNA translation. The activation of ISR plays a pivot
Externí odkaz:
https://doaj.org/article/18af2fe7b35548578596dd8ed96f88ce
Autor:
Niklas Ravn-Boess, Nainita Roy, Takamitsu Hattori, Devin Bready, Hayley Donaldson, Christopher Lawson, Cathryn Lapierre, Aryeh Korman, Tori Rodrick, Enze Liu, Joshua D. Frenster, Gabriele Stephan, Jordan Wilcox, Alexis D. Corrado, Julia Cai, Rebecca Ronnen, Shuai Wang, Sara Haddock, Jonathan Sabio Ortiz, Orin Mishkit, Alireza Khodadadi-Jamayran, Aris Tsirigos, David Fenyö, David Zagzag, Julia Drube, Carsten Hoffmann, Fabiana Perna, Drew R. Jones, Richard Possemato, Akiko Koide, Shohei Koide, Christopher Y. Park, Dimitris G. Placantonakis
Publikováno v:
Cell Reports, Vol 42, Iss 11, Pp 113374- (2023)
Summary: Glioblastoma (GBM) is the most common and aggressive primary brain malignancy. Adhesion G protein-coupled receptors (aGPCRs) have attracted interest for their potential as treatment targets. Here, we show that CD97 (ADGRE5) is the most promi
Externí odkaz:
https://doaj.org/article/e954f101e34e4454841a124bf6a6e405
Autor:
Ravn-Boess, Niklas, Roy, Nainita, Hattori, Takamitsu, Bready, Devin, Donaldson, Hayley, Lawson, Christopher, Lapierre, Cathryn, Korman, Aryeh, Rodrick, Tori, Liu, Enze, Frenster, Joshua D., Stephan, Gabriele, Wilcox, Jordan, Corrado, Alexis D., Cai, Julia, Ronnen, Rebecca, Wang, Shuai, Haddock, Sara, Sabio Ortiz, Jonathan, Mishkit, Orin, Khodadadi-Jamayran, Alireza, Tsirigos, Aris, Fenyö, David, Zagzag, David, Drube, Julia, Hoffmann, Carsten, Perna, Fabiana, Jones, Drew R., Possemato, Richard, Koide, Akiko, Koide, Shohei, Park, Christopher Y., Placantonakis, Dimitris G.
Publikováno v:
In Cell Reports 28 November 2023 42(11)
Autor:
Buckheit, Katherine A., Barden, Eileen, Shaw, Rachael, Possemato, Kyle, Mastroleo, Nadine R., Rauch, Sheila A.M.
Publikováno v:
In Cognitive and Behavioral Practice August 2023 30(3):551-563